Researchers have developed methods to study and manipulate areas of the brain, though many of those methods are restricted by the limited depth that light can reach within the brain. A multidisciplinary team at Washington University in St. Louis plans to overcome that limitation by integrating ultrasound with genetics to precisely modify neurons in the […]
The National Institutes of General Medical Sciences has awarded an Outstanding Investigator Award of nearly $2 million to Paul Taghert, PhD, Professor of Neuroscience at Washington University School of Medicine, to study how the circadian clock orchestrates multiple biological cycles that operate at different phases. Physiological and behavioral rhythms, such as sleep, hormone fluxes, and eating, […]
A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS), a paralyzing neurological disease. Known as tofersen, the drug has been shown to slow progression of the deadly disease. International clinical trials of tofersen, developed by the global biotechnology company Biogen Inc., […]
More research needed to determine if sleep medications prevent, delay Alzheimer’s
Findings could lead to universal therapies for alcohol, tobacco, cannabis, opioid addictions
Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein
Honored for work developing new kind of therapy for neurodegenerative diseases
The neurologist and physician scientist at Washington University in St. Louis provided insight on the general dieting strategies patients with multiple sclerosis should take as more information becomes available. [WATCH TIME: 6 minutes]
Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases
“These trials don’t go without huge input and commitment from the participants and of course, their caregivers, and the clinical trial sites. I have the privilege of speaking to you about the trial as the lead author of this paper, but this is a team effort and includes a large group of people from multiple […]
Findings could help explain rare symptoms such as problems with language, vision
Installation talk, titled “For Whom the Bells Toll: Networked Circadian Clocks and Clock Watchers”
Findings in mice suggest new therapeutic approach to Alzheimer’s, other age-related diseases
Funding from NIH HEAL Initiative
Neurons made from Huntington’s disease patients’ skin cells shed light on cognitive decline
Extended use of tofersen may help stabilize muscle strength, control
Research finds kids with prenatal exposure show more signs of psychopathology
WashU was first to reveal the intricate link between fragmented sleep and dementia
Diagnosing, treating sleep apnea may make driving safer for older adults
Five-year $2 million grant from NIH
Too little and too much sleep linked to cognitive decline
Animal study could help ID new treatment targets for negative emotions linked to pain
Neuroscientist receives award from Brain & Behavior Research Foundation
International team seeks hidden signs of brain damage in REM behavior disorder
For humans and animals, many aspects of normal behavior and physiology rely on the proper functioning of the body’s circadian clocks.
Alzheimer’s dementia predicted by brain amyloid levels, age
Research indicates problematic marijuana use is correlated with poorer COVID-19 outcomes
The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional clinical and basic research in mental illness. The prizes are awarded annually to honor the work of outstanding scientists who have been supported by the Foundation’s Young Investigator Grants Program. “The Klerman and Freedman prizes […]
Brain protein reduces Alzheimer’s-like brain damage in mice
Immune cells from skull bone marrow guard the brain, spinal cord
Tom Burris, Ph.D., FAAAS, FAHA, Alumni Chair in Pharmaceutical Education and vice president for research at University of Health Sciences and Pharmacy in St. Louis, has received a $150,000 grant from the Washington University School of Medicine in St. Louis’ Philip and Sima Needleman Center for Autophagy Therapeutics and Research to support research related to […]
Impaired drainage also may play a role in Alzheimer’s in people
Further studies underway to determine extent of clinical benefits
Study indicates timing of chemotherapy could improve treatment for deadly brain cancer